Hoechst Arava Pregnancy Registry Recommended To Track Teratogenicity
Executive Summary
A pregnancy registry should be established to monitor possible teratogenic effects of Hoechst Marion Roussel's rheumatoid arthritis immunotherapy Arava (leflunomide) the Arthritis Advisory Committee recommended Aug. 7.